International Flavors & Fragrances Health & Biosciences — Additional charges, net decreased by 71.4% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $3.00M to $2.00M. Over 3 years (FY 2022 to FY 2025), Health & Biosciences — Additional charges, net shows an upward trend with a 111.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher one-time operational disruptions or restructuring activities, while a decrease indicates lower non-core costs.
Represents non-recurring or unusual expenses incurred by the Health & Biosciences segment that are excluded from core op...
Similar to 'Restructuring and other charges' or 'Special items' reported by peer specialty chemical and ingredient companies.
iff_segment_health_biosciences_additional_charges_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $1.00M | $0.00 | $1.00M | $1.00M | $0.00 | $10.00M | $1.00M | $1.00M | $1.00M | $1.00M | $0.00 | $0.00 | $0.00 | $3.00M | $5.00M | $4.00M | $7.00M | $2.00M |
| QoQ Change | — | -75.0% | -100.0% | — | +0.0% | -100.0% | — | -90.0% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | +66.7% | -20.0% | +75.0% | -71.4% |
| YoY Change | — | — | — | -75.0% | +0.0% | — | — | +0.0% | +0.0% | — | -90.0% | -100.0% | -100.0% | -100.0% | +200.0% | — | — | — | -33.3% |